Composition of Rinonorma
Depending on the type of nasal spray Rinonorm, the composition is 10 ml. of this medicine may contain either 5 mg. (for children) or 10 mg. (for adults) the active substance xylometazoline hydrochloride .
In addition, the preparation contains such auxiliary compounds as: 85% glycerol , citric acid monohydrate, sodium citrate dihydrate, as well as water intended for injection.
Pharmacodynamics and pharmacokinetics
This nasal spray is actively used for topical use in the practice of ENT doctors. the xylometazoline contained in the drops is an alpha-adrenergic agonist, this active compound helps to constrict arterioles , which has a beneficial effect on the nasopharyngeal mucosa by reducing swelling and eliminating hyperemia.
Rinonorm helps reduce the amount of secretions within a few seconds after topical application. The medicinal effect of the drops lasts for several more hours. The medicine restores the patency of the nasal passages, Eustachian tubes, and also the openings of the sinuses.
Under the influence of nasal drops, the well-being of patients significantly improves by restoring the air patency of the nasopharynx , and also reduces the likelihood of developing complications that inevitably arise with prolonged stagnation of secretions.
Rinonorm spray naz doses 0.1% 20 ml x1
Rinonorm-Teva spray naz doses 0.1% 20 ml x1, ATX code: R01AA07 (Xylometazoline) Active substance: xylometazoline (xylometazoline) Rec.INN registered by WHO
Dosage forms
RINONORM
nasal spray dosage. (for children) 0.05% ml: fl. , with dosage device and nozzle for nose rings. No.: P N014799/02 dated 04/24/09 - Indefinitely
dosed nasal spray 0.1%: fl. with dosage device and nozzle for nose rings. No.: P N014799/01 dated 04/13/09 - Indefinitely
Release form, composition and packaging
Dosed nasal spray (for children) 0.05% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 500 mcg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Nasal spray dosed 0.1% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 1 mg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Clinical-pharmacological group: Vasoconstrictor drug for topical use in ENT practice Pharmaco-therapeutic group: Anticongestant - vasoconstrictor (alpha-adrenergic agonist)
pharmachologic effect
Alpha adrenergic agonist for local use in ENT practice.
When applied topically, xylometazoline causes constriction of arterioles, leading to a decrease in hyperemia and swelling of the mucous membranes of the nasopharynx and a decrease in secretion. A distinct local effect of the drug is detected within a few minutes and persists for several hours (up to 6-8 hours), manifesting itself in the restoration of patency of the nasal passages, sinus openings and Eustachian tubes. Restoring air patency of the nasopharynx improves the patient’s well-being and reduces the risk of possible complications caused by stagnation of mucous secretion.
Pharmacokinetics: When applied topically, xylometazoline is practically not absorbed, so plasma concentrations are very low (not analytically determined).
Indications
Rinonorm is used as symptomatic therapy for the following diseases and conditions:
- acute viral or bacterial rhinitis,
- acute allergic rhinitis,
- acute sinusitis or exacerbation of chronic sinusitis,
- acute otitis media (to reduce swelling of the mucous membrane of the Eustachian tube),
— preparing the patient for diagnostic procedures in the nasal passages.
ICD-10 codes
Dosage regimen
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
The maximum possible use of the drug is no more than 7 times a day. The interval between drug administration should not be less than 6 hours.
The amount of liquid entering the patient’s nasal passage (1 dose) is 0.14 ml of solution.
To avoid complications in the form of resumption of symptoms of the disease, the duration of continuous use of the drug should not exceed 7 days.
Before using the drug, you should clear the nasal passages of secretions. During administration of the drug, you should take a light breath through the nose.
Side effect
Local reactions: burning sensation and dryness of the nasal mucosa, rarely - irritation of the nasal mucosa, oral cavity and larynx.
From the side of the central nervous system: rarely - headache, extremely rarely (<1/10,000) - insomnia, increased excitability.
From the cardiovascular system: extremely rarely (<1/10,000) - arrhythmia, increased blood pressure.
Other: rarely - nausea, extremely rarely (<1/10,000) - skin reactions.
Contraindications for use
- atrophic (dry) rhinitis,
- angle-closure glaucoma,
- condition after hypophysectomy,
- simultaneous use of MAO inhibitors and tricyclic antidepressants,
- children under 2 years of age (for spray for children),
- children under 10 years of age (for adult spray),
- hypersensitivity to xylometazoline or other components of the drug.
The drug should be used with caution in patients with arterial hypertension, severe heart disease, hyperthyroidism, diabetes mellitus and patients taking bromocriptine.
Use during pregnancy and breastfeeding
The drug should not be taken during pregnancy.
The drug should be used with caution during breastfeeding.
Use in children
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Contraindication: children under 2 years of age (for spray for children), children under 10 years of age (for spray for adults).
special instructions
Impact on the ability to drive vehicles and operate machinery
There was no effect on the ability to drive vehicles or control machines and mechanisms.
Overdose
Symptoms: in rare cases of overdose, occurring mainly in children, arrhythmia, increased blood pressure, and in some cases loss of consciousness may be observed.
Treatment: symptomatic therapy under supervision is indicated. In serious cases, non-selective alpha-blockers can be used to lower blood pressure, as well as intubation and mechanical ventilation. Vasoconstrictor drugs are contraindicated. If you accidentally ingest a moderate or large amount of the drug, you should take activated charcoal and a laxative (for example, sodium sulfate), and do a gastric lavage.
Drug interactions
Concomitant use of tri- or tetracyclic antidepressants may increase the systemic exposure of xylometazoline.
When taking the drug simultaneously with MAO inhibitors, there may be a risk of increased blood pressure.
Storage conditions and periods
The drug should be stored out of the reach of children at a temperature not exceeding 25°C. Shelf life - 3 years, after opening the bottle - 1 year.
Conditions for dispensing from pharmacies The drug is approved for use as an over-the-counter product.
Indications for use
Rinonorm is indicated for use in the therapeutic treatment of rhinitis (allergic, bacterial or viral), sinusitis (in acute or chronic acute phases), as well as to eliminate swelling of the mucous membranes of the Eustachian tube in otitis media . In addition, drops are used as a preparatory agent before carrying out diagnostic manipulations in the nasal passages.
Rinonorm nasal spray 0.1% 20ml
Rinonorm nasal spray 0.1% 20ml
Trade name
: Rhinonorm
International nonproprietary or chemical name:
xylometazoline
Dosage form
: dosed nasal spray
Composition: 1 dose of the drug contains
active substance:
xylometazoline hydrochloride 0.14 mg;
Excipients:
benzalkonium chloride (in the form of a 50% solution) 0.056 mg in terms of benzalkonium chloride 0.028 mg, citric acid monohydrate 0.07 mg, sodium citrate dihydrate 0.364 mg, glycerol 85% 3.36 mg, purified water 136.71 mg.
Description
Transparent almost colorless solution.
Pharmacological group:
anticongestive agent - alpha-adrenergic agonist.
pharmachologic effect
:
Xylometazoline is an alpha-adrenergic agonist used for topical use in ENT practice.
When applied topically, xylometazoline causes constriction of arterioles, which leads to a decrease in hyperemia and swelling of the mucous membranes of the nasopharynx and a decrease in secretion. A distinct local effect of the drug is detected within a few minutes and persists for several hours (up to 6-8 hours), manifesting itself in the restoration of patency of the nasal passages, sinus openings and eustachian tubes. Restoring the air patency of the nasopharynx improves the well-being of patients and reduces the risk of possible complications caused by stagnation of mucous secretions.
Pharmacokinetics:
When applied topically, xylometazoline is practically not absorbed, so the concentrations in the blood plasma are very small (not analytically determined).
Indications for use
:
As a symptomatic treatment for the following diseases and conditions:
- acute viral or bacterial rhinitis; - acute allergic rhinitis; - acute sinusitis or exacerbation of chronic sinusitis; - acute otitis media (to reduce swelling of the mucous membrane of the Eustachian tube); — preparing patients for diagnostic procedures in the nasal passages.
Contraindications
:
- hypersensitivity to xylometazoline or other components of the drug; - inflammation of the skin, nasal mucosa and crust formation (dry rhinitis); - use after hypophysectomy; - use in children under 10 years of age; - angle-closure glaucoma; - taking monoamine oxidase inhibitors (MAO) and tricyclic antidepressants.
Carefully
:
Use with caution in patients with arterial hypertension, severe cardiac disease, hyperthyroidism, diabetes mellitus, patients taking bromocriptine and patients with long QT interval syndrome.
Use during pregnancy and lactation
:
The drug should not be taken during pregnancy. Use with caution during breastfeeding.
Directions for use and doses
Adults and children over 10 years old:
1 dose (one press on the piston device) in each nasal passage no more than 3 times a day (the maximum dose should not exceed 7 times a day). The interval between drug administration should not be less than 6 hours.
1 dose = 0.14 ml solution, 140 mcg.
To avoid complications in the form of resumption of symptoms of the disease, the duration of continuous use of the drug should not exceed 7 days.
Before using the drug, it is recommended to clear the nasal passage of secretions, and during the administration of the drug, you must take a light breath through the nose.
Side effect
:
Sensation of burning and dryness of the nasal mucosa;
in rare cases - irritation of the nasal mucosa, oral cavity and larynx, headache and nausea;
extremely rare (<1/10000) - arrhythmia, increased blood pressure, increased excitability, skin reactions.
Overdose
:
In rare cases of overdose, which occurs mainly in children, the following symptoms may be observed: irregular pulse, increased blood pressure, and in some cases, loss of consciousness. In case of overdose, symptomatic treatment under supervision is indicated.
In serious cases, non-selective alpha-blockers may be used to lower blood pressure, as well as intubation and mechanical ventilation. Vasoconstrictor drugs are contraindicated.
If you accidentally take a moderate or large amount of the drug orally, you should take activated carbon (adsorbent) and sodium sulfate (laxative), and do a gastric lavage.
Interaction with other drugs
:
Concomitant use of tri- or tetracyclic antidepressants may increase the systemic exposure of xylometazoline. When taking the drug simultaneously with monoamine oxidase inhibitors (MAOIs), there may be a risk of increased blood pressure.
special instructions
:
Patients with long QT syndrome taking xylometazoline may be at increased risk of serious ventricular arrhythmias.
Impact on the ability to drive vehicles and machinery
:
There was no effect on the ability to drive vehicles or control machines and mechanisms.
Release form
Nasal spray dosed 0.1%.
15 ml or 20 ml in a dark glass bottle with a dispensing device for spraying, a nozzle for the nose and a protective cap.
1 bottle along with instructions for use in a cardboard box, on which additional protective stickers can be applied.
Storage conditions
:
Store at a temperature not exceeding 25 0C
Keep out of the reach of children!
Best before date
3 years.
After opening the bottle, the drug is suitable for use for 1 year.
Do not use after the expiration date.
Vacation conditions
Dispensed without a prescription
Contraindications Rinonorma
Absolute contraindications for Rinonorm include the following cases:
- dry or atrophic rhinitis;
- angle-closure glaucoma;
- patient age under 2 years;
- hypersensitivity to the main and auxiliary components of the drug compound.
It is not recommended to use these nasal drops in conditions following hypophysectomy , as well as when taking tricyclic antidepressants and MAO inhibitors ( monoamine oxidase ).
Rinonorm-Teva spray naz doses for children 0.05% 20 ml x1
Rinonorm-Teva spray naz doses for children 0.05% 20 ml x1
ATX code: R01AA07 (Xylometazoline) Active substance: xylometazoline (xylometazoline) Rec.INN registered by WHO
Dosage forms
RINONORM
nasal spray dosage. (for children) 0.05% ml: fl. , with dosage device and nozzle for nose rings. No.: P N014799/02 dated 04/24/09 - Indefinitely
dosed nasal spray 0.1%: fl. with dosage device and nozzle for nose rings. No.: P N014799/01 dated 04/13/09 - Indefinitely
Release form, composition and packaging
Dosed nasal spray (for children) 0.05% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 500 mcg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Nasal spray dosed 0.1% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 1 mg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Clinical-pharmacological group: Vasoconstrictor drug for topical use in ENT practice Pharmaco-therapeutic group: Anticongestant - vasoconstrictor (alpha-adrenergic agonist)
pharmachologic effect
Alpha adrenergic agonist for local use in ENT practice.
When applied topically, xylometazoline causes constriction of arterioles, leading to a decrease in hyperemia and swelling of the mucous membranes of the nasopharynx and a decrease in secretion. A distinct local effect of the drug is detected within a few minutes and persists for several hours (up to 6-8 hours), manifesting itself in the restoration of patency of the nasal passages, sinus openings and Eustachian tubes. Restoring air patency of the nasopharynx improves the patient’s well-being and reduces the risk of possible complications caused by stagnation of mucous secretion.
Pharmacokinetics: When applied topically, xylometazoline is practically not absorbed, so plasma concentrations are very low (not analytically determined).
Indications
Rinonorm is used as symptomatic therapy for the following diseases and conditions:
- acute viral or bacterial rhinitis,
- acute allergic rhinitis,
- acute sinusitis or exacerbation of chronic sinusitis,
- acute otitis media (to reduce swelling of the mucous membrane of the Eustachian tube),
— preparing the patient for diagnostic procedures in the nasal passages.
ICD-10 codes
Dosage regimen
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
The maximum possible use of the drug is no more than 7 times a day. The interval between drug administration should not be less than 6 hours.
The amount of liquid entering the patient’s nasal passage (1 dose) is 0.14 ml of solution.
To avoid complications in the form of resumption of symptoms of the disease, the duration of continuous use of the drug should not exceed 7 days.
Before using the drug, you should clear the nasal passages of secretions. During administration of the drug, you should take a light breath through the nose.
Side effect
Local reactions: burning sensation and dryness of the nasal mucosa, rarely - irritation of the nasal mucosa, oral cavity and larynx.
From the side of the central nervous system: rarely - headache, extremely rarely (<1/10,000) - insomnia, increased excitability.
From the cardiovascular system: extremely rarely (<1/10,000) - arrhythmia, increased blood pressure.
Other: rarely - nausea, extremely rarely (<1/10,000) - skin reactions.
Contraindications for use
- atrophic (dry) rhinitis,
- angle-closure glaucoma,
- condition after hypophysectomy,
- simultaneous use of MAO inhibitors and tricyclic antidepressants,
- children under 2 years of age (for spray for children),
- children under 10 years of age (for adult spray),
- hypersensitivity to xylometazoline or other components of the drug.
The drug should be used with caution in patients with arterial hypertension, severe heart disease, hyperthyroidism, diabetes mellitus and patients taking bromocriptine.
Use during pregnancy and breastfeeding
The drug should not be taken during pregnancy.
The drug should be used with caution during breastfeeding.
Use in children
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Contraindication: children under 2 years of age (for spray for children), children under 10 years of age (for spray for adults).
special instructions
Impact on the ability to drive vehicles and operate machinery
There was no effect on the ability to drive vehicles or control machines and mechanisms.
Overdose
Symptoms: in rare cases of overdose, occurring mainly in children, arrhythmia, increased blood pressure, and in some cases loss of consciousness may be observed.
Treatment: symptomatic therapy under supervision is indicated. In serious cases, non-selective alpha-blockers can be used to lower blood pressure, as well as intubation and mechanical ventilation. Vasoconstrictor drugs are contraindicated. If you accidentally ingest a moderate or large amount of the drug, you should take activated charcoal and a laxative (for example, sodium sulfate), and do a gastric lavage.
Drug interactions
Concomitant use of tri- or tetracyclic antidepressants may increase the systemic exposure of xylometazoline.
When taking the drug simultaneously with MAO inhibitors, there may be a risk of increased blood pressure.
Storage conditions and periods
The drug should be stored out of the reach of children at a temperature not exceeding 25°C. Shelf life - 3 years, after opening the bottle - 1 year.
Conditions for dispensing from pharmacies The drug is approved for use as an over-the-counter product.
Side effects
Quite rarely, however, the following side effects may occur:
- increased excitability;
- headache;
- increased blood pressure;
- arrhythmia;
- insomnia;
- nausea;
- irritation of mucous membranes;
- burning or itching;
- skin rashes.
Rinonorm, instructions for use (Method and dosage)
Instructions for use of Rinonorm differ depending on the type of drops. A children's spray containing a 0.05% xylometazoline solution is prescribed one dose (equivalent to one press of the dispenser - 0.14 ml) into each nostril no more than three times a day.
For adult patients, as well as children over the age of 10 years, a drug containing 0.1% xylometazoline is prescribed in a dosage equal to one press on the piston device in each nostril no more than three times a day.
The total duration of use of the medicine should not exceed seven days. It is advisable to maintain a six-hour interval between the use of drops. To enhance the effectiveness of the spray, it is worth clearing the nasal sinuses of secretions before using it.
Rinonorm-Teva
Rinonorm-Teva spray naz doses for children 0.05% 20 ml x1
ATX code: R01AA07 (Xylometazoline) Active substance: xylometazoline (xylometazoline) Rec.INN registered by WHO
Dosage forms
RINONORM
nasal spray dosage. (for children) 0.05% ml: fl. , with dosage device and nozzle for nose rings. No.: P N014799/02 dated 04/24/09 - Indefinitely
dosed nasal spray 0.1%: fl. with dosage device and nozzle for nose rings. No.: P N014799/01 dated 04/13/09 - Indefinitely
Release form, composition and packaging
Dosed nasal spray (for children) 0.05% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 500 mcg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Nasal spray dosed 0.1% in the form of a clear, colorless solution.
1 ml
xylometazoline hydrochloride 1 mg
Excipients: citric acid monohydrate, sodium citrate dihydrate, glycerol 85%, water for injection.
Clinical-pharmacological group: Vasoconstrictor drug for topical use in ENT practice Pharmaco-therapeutic group: Anticongestant - vasoconstrictor (alpha-adrenergic agonist)
pharmachologic effect
Alpha adrenergic agonist for local use in ENT practice.
When applied topically, xylometazoline causes constriction of arterioles, leading to a decrease in hyperemia and swelling of the mucous membranes of the nasopharynx and a decrease in secretion. A distinct local effect of the drug is detected within a few minutes and persists for several hours (up to 6-8 hours), manifesting itself in the restoration of patency of the nasal passages, sinus openings and Eustachian tubes. Restoring air patency of the nasopharynx improves the patient’s well-being and reduces the risk of possible complications caused by stagnation of mucous secretion.
Pharmacokinetics: When applied topically, xylometazoline is practically not absorbed, so plasma concentrations are very low (not analytically determined).
Indications
Rinonorm is used as symptomatic therapy for the following diseases and conditions:
- acute viral or bacterial rhinitis,
- acute allergic rhinitis,
- acute sinusitis or exacerbation of chronic sinusitis,
- acute otitis media (to reduce swelling of the mucous membrane of the Eustachian tube),
— preparing the patient for diagnostic procedures in the nasal passages.
ICD-10 codes
Dosage regimen
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
The maximum possible use of the drug is no more than 7 times a day. The interval between drug administration should not be less than 6 hours.
The amount of liquid entering the patient’s nasal passage (1 dose) is 0.14 ml of solution.
To avoid complications in the form of resumption of symptoms of the disease, the duration of continuous use of the drug should not exceed 7 days.
Before using the drug, you should clear the nasal passages of secretions. During administration of the drug, you should take a light breath through the nose.
Side effect
Local reactions: burning sensation and dryness of the nasal mucosa, rarely - irritation of the nasal mucosa, oral cavity and larynx.
From the side of the central nervous system: rarely - headache, extremely rarely (<1/10,000) - insomnia, increased excitability.
From the cardiovascular system: extremely rarely (<1/10,000) - arrhythmia, increased blood pressure.
Other: rarely - nausea, extremely rarely (<1/10,000) - skin reactions.
Contraindications for use
- atrophic (dry) rhinitis,
- angle-closure glaucoma,
- condition after hypophysectomy,
- simultaneous use of MAO inhibitors and tricyclic antidepressants,
- children under 2 years of age (for spray for children),
- children under 10 years of age (for adult spray),
- hypersensitivity to xylometazoline or other components of the drug.
The drug should be used with caution in patients with arterial hypertension, severe heart disease, hyperthyroidism, diabetes mellitus and patients taking bromocriptine.
Use during pregnancy and breastfeeding
The drug should not be taken during pregnancy.
The drug should be used with caution during breastfeeding.
Use in children
Children aged 2 to 10 years are prescribed Rinonorm nasal spray for children 0.05%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Adults and children over 10 years of age are prescribed Rinonorm nasal spray 0.1%, 1 dose (1 press on the piston device) in each nasal passage no more than 3 times a day.
Contraindication: children under 2 years of age (for spray for children), children under 10 years of age (for spray for adults).
special instructions
Impact on the ability to drive vehicles and operate machinery
There was no effect on the ability to drive vehicles or control machines and mechanisms.
Overdose
Symptoms: in rare cases of overdose, occurring mainly in children, arrhythmia, increased blood pressure, and in some cases loss of consciousness may be observed.
Treatment: symptomatic therapy under supervision is indicated. In serious cases, non-selective alpha-blockers can be used to lower blood pressure, as well as intubation and mechanical ventilation. Vasoconstrictor drugs are contraindicated. If you accidentally ingest a moderate or large amount of the drug, you should take activated charcoal and a laxative (for example, sodium sulfate), and do a gastric lavage.
Drug interactions
Concomitant use of tri- or tetracyclic antidepressants may increase the systemic exposure of xylometazoline.
When taking the drug simultaneously with MAO inhibitors, there may be a risk of increased blood pressure.
Storage conditions and periods
The drug should be stored out of the reach of children at a temperature not exceeding 25°C. Shelf life - 3 years, after opening the bottle - 1 year.
Conditions for dispensing from pharmacies The drug is approved for use as an over-the-counter product.
Analogues of Rinonorm
Level 4 ATX code matches:
Xymelin Eco
Xymelin
Nazivin
Galazolin
Lazorin
Nazivin Sensitive for children
Otrivin
Naphthyzin
Sanorin
Knoxprey
For the nose
Lazolvan Rino
Afrin
Rhinorus
Eucazoline Aqua
Rinazolin
Grippostad Reno
Farmazolin
Xylometazoline
Nazol Advance
Among the main analogues of Rinonorm are:
- Galazolin;
- Nose Spray;
- Brizolin;
- Theiss Nazolin;
- NOS asterisk;
- Xylene;
- Xylometazoline;
- Influrin;
- Xymelin;
- Nosolin;
- Olint;
- Rinomaris;
- Otrivin;
- Rhinorus;
- Snoop;
- Rhinostop;
- Eucazoline Aqua;
- Sanorin-Xylo;
- Tizin Xylo;
- Espazolin;
- Suprima-NOZ;
- Farmazolin.
Price Rinonorma, where to buy
As a rule, the average price of Rinonorm (15 ml bottle), both for adults and for children, varies from 60 to 70 rubles.
- Online pharmacies in RussiaRussia
ZdravCity
- Rhinonorm sp.
called dosage 0.1% fl. 20ml Merkle GmbH 82 rub. order - Rhinonorm sp. called dosage (for children) 0.05% fl. 20ml Merkle GmbH
93 RUR order
- Rinonorm Comfort sp. called dosage 0.1 mg+5 mg/dose vial. 10ml (90 doses) Merkle GmbH
167 RUR order
- Rinonorm Comfort sp. called dosage 0.05mg+5mg/dose vial. 10ml (90 doses) Merkle GmbH
RUB 165 order
